2-ethylsulfanyl-5-phenyl-1,3,4-oxadiazole | 55084-89-4

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 2-ethylsulfanyl-5-phenyl-1,3,4-oxadiazole
• 英文别名: 2-phenyl-5-ethylthio-1,3,4-oxadiazole；2-(ethylthio)-5-phenyl-1,3,4-oxadiazole；2-Phenyl-5-ethylthio-1,3,4-oxadiazol；2-Aethylthio-5-phenyl-1,3,4-oxadiazol；2-Ethylthio-5-phenyl-1,3,4-oxadiazol
• CAS: 55084-89-4
• 化学式: C₁₀H₁₀N₂OS
• 分子量: 206.268
• InChiKey: TXZJGJDQANIVIV-UHFFFAOYSA-N

物化性质

• 熔点：
  39-40 °C(Solv: ligroine (8032-32-4))
• 沸点：
  343.6±25.0 °C(Predicted)
• 密度：
  1.25±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  64.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-ethylsulfanyl-5-phenyl-1,3,4-oxadiazole 在 potassium permanganate 、 溶剂黄146 作用下， 反应 0.17h， 生成 2-(ethylsulfonyl)-5-phenyl-1,3,4-oxadiazole
  参考文献：
  名称：

  Inhibition of Tobacco Bacterial Wilt with Sulfone Derivatives Containing an 1,3,4-Oxadiazole Moiety

  摘要：

  A series of new sulfone compounds containing the 1,3,4-oxadiazole moiety were designed and synthesized. Their structures were identified by H-1 and C-13 nuclear magnetic resonance and elemental analyses. Antibacterial bioassays indicated that most compounds exhibited promising in vitro antibacterial bioactivities against tobacco bacterial wilt at 200 mu g/mL. The relationship between structure and antibacterial activity was also discussed. Among the title compounds, 5'c:, 5'h, 5'i, and 5, could inhibit mycelia growth of Ralstonia solanacearum in vitro by approximately 50% (EC50) at 39.8, 60.3, 47.9, and 32.1 mu g/mL, respectively. Among them, compound 5) was identified as the most promising candidate due to its stronger effect than that of Kocide 3000 [Cu(OH)(2)] within the same concentration range. Field trials demonstrated that the control effect of compound 55 against tobacco bacterial wilt was better than that of the commercial bactericide Saisentong. For the first time, the present work demonstrated that sulfone derivatives containing 1,3,4-oxadiazole can be used to develop potential bactericides for plants.

  DOI：

  10.1021/jf203772d
• 作为产物：
  描述：

  2-phenyl-4-ethoxycarbonyl-1,3,4-oxodiazole-5(4H)-thione 生成 2-ethylsulfanyl-5-phenyl-1,3,4-oxadiazole
  参考文献：
  名称：

  Mitra,R.B. et al., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1978, vol. 16, p. 146 - 148

  摘要：

  DOI：

文献信息

• Synthesis of 1,3,4-Oxadiazoles Using Polymer-supported Reagents
  作者：Christopher T. Brain、Shirley A. Brunton

  DOI：10.1055/s-2001-11404

  日期：——

  The preparation of a novel polystyrene-supported dehydrating agent and its application to the synthesis of 1,3,4-oxadiazoles under thermal and microwave conditions is described. An alternative procedure using tosyl chloride and P-BEMP is also presented.

  本文描述了一种新型聚苯乙烯支持的脱水剂的制备及其在热条件和微波条件下合成1,3,4-恶二唑的应用。同时，也介绍了一种使用对甲苯磺酰氯和P-BEMP的替代方法。
• One-pot Synthesis of 2-Alkylthio-1,3,4-oxadiazole and Bis-(1,3,4-oxadiazole-2-yl)thio alkyl Derivatives from Acid Hydrazides and CS2
  作者：Mohammad Soleiman-Beigi、Mohammad Alikarami、Tahereh Hosseinzadeh

  DOI：10.14233/ajchem.2013.14148

  日期：——

  An efficient and one-pot method for synthesis of 2-alkylthio-1,3,4-oxadiazole derivatives in mild conditions is described. Some novel derivatives such as bis-1,3,4-oxadiazole analogs are also synthesized.

  介绍了一种在温和条件下合成 2-烷硫基-1,3,4-恶二唑衍生物的高效单锅方法。此外，还合成了一些新型衍生物，如双-1,3,4-恶二唑类似物。
• Novel Synthesis of Oxadiaza Heterocycles and Thiadiazocine Derivatives†
  作者：Nasr K. Mohamed

  DOI：10.1039/a607724b

  日期：——

  Ethyl 3-benzoyldithiocarbazate 1 and ethyl dithiocarbazate 2 react with different π-acceptors to give the title products.

  3-苯甲酰二硫代氨基甲酸乙酯1和乙基 二硫代氨基甲酸酯2与不同的α-受体反应，得到 标题产品。
• [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS DE L'HISTONE DEACETYLASE
  申请人：METHYLGENE INC

  公开号：WO2004069823A1

  公开（公告）日：2004-08-19

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  该发明涉及抑制组蛋白去乙酰化酶的技术。该发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病症的组合物和方法。
• COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS
  申请人：THE BROAD INSTITUTE, INC.

  公开号：US20160031870A1

  公开（公告）日：2016-02-04

  Disclosed are compounds that can be used for treating tuberculosis.

  本发明涉及用于治疗结核病的化合物。